$560,000 of MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 1835: Saving Access to Laboratory Services Act; H.R. 1770, S.2477: Equitable Community Access to Pharmacist Services Act; H.R. 4011 Timely Access to Cancer Treatment; Medically integrated physician dispensing regulations; S.127, PBM Transparency Act; Drug price transparency and cost savings opportunities.
H.R.5376 The Inflation Reduction Act.
H.R.5376 The Inflation Reduction Act.
H.R. 1770, S.2477: Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness and response; PAHPA reauthorization H.R. 4420 and 4421, S.2333; Healthcare innovation, ARPA-H, oncology research; H.R. 1835: Saving Access to Laboratory Services Act; Community Health Center Reauthorization; Benefit cost and transparency, real time benefit tools and patient APIs - S. 1339; Controlled Substance Reporting - H.R. 501; Pharmaceutical Manufacturing and Supply Chain Shortage - H.R. 3793; Alleviating drug shortages; H.R. 7623: Telehealth Modernization Act of 2024; H.R.4011 Timely Access to Cancer Treatment Act; H.R.2630, S.652 The Safe Step Act; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3561, PATIENT Act; H.R. 4473, Medicare Patient Access to Cancer Treatment Act.
H.R. 1770, S.2477: Equitable Community Access to Pharmacist Services Act; Healthcare innovation and oncology research; H.R.3173, S.3018 The Improving Seniors Timely Access to Care Act; Medically integrated physician dispensing regulations."
You can find more data on corporate lobbying on Quiver Quantitative.
MCK Congressional Stock Trading
Members of Congress have traded $MCK stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MCK stock by members of Congress over the last 6 months:
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 10/01 and 0 sales.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 09/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MCK Insider Trading Activity
MCK insiders have traded $MCK stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $MCK stock by insiders over the last 6 months:
- BRIAN S. TYLER (Chief Executive Officer) has made 0 purchases and 2 sales selling 7,506 shares for an estimated $4,455,298.
- LEANN B SMITH (EVP & Chief HR Officer) has made 0 purchases and 2 sales selling 1,158 shares for an estimated $680,672.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MCK Hedge Fund Activity
We have seen 614 institutional investors add shares of MCK stock to their portfolio, and 812 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,215,981 shares (+541.9%) to their portfolio in Q3 2024, for an estimated $1,095,625,326
- ROYAL BANK OF CANADA added 905,177 shares (+115.6%) to their portfolio in Q3 2024, for an estimated $447,537,612
- INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC removed 805,347 shares (-99.8%) from their portfolio in Q4 2024, for an estimated $458,975,308
- APPLIED FINANCE CAPITAL MANAGEMENT, LLC added 577,611 shares (+1071.3%) to their portfolio in Q3 2024, for an estimated $285,582,430
- WELLINGTON MANAGEMENT GROUP LLP removed 565,939 shares (-98.6%) from their portfolio in Q3 2024, for an estimated $279,811,560
- LONE PINE CAPITAL LLC removed 560,936 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $277,337,977
- FRANKLIN RESOURCES INC added 541,113 shares (+21.5%) to their portfolio in Q3 2024, for an estimated $267,537,089
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
